Biologics Safety Testing Market - Global Forecast to 2026

1
Request Sample
2
Biologics Safety Testing Market worth 6.2
billion by 2026
MARKET OPPORTUNITY OVER NEXT 5 YEARS
TWO OF THE KEY DRIVERS OF THE MARKET WILL BE
KEY MARKET PLAYERS
CAGR of 12.4
2021 2026

• Charles River Laboratories, Inc. (US)
• Lonza (Switzerland)
• Thermo Fisher Scientific, Inc. (US)
• Merck KGaA (Germany)

CAGR

• The monoclonal antibodies manufacturing segment
  accounted for the largest market share of the
  Biologics safety testing market

The Asia Pacific region is the fastest growing
region of the Biologics safety testing market
Market Segmentation by Equipment category

• The residual host-cell proteins and DNA detection
  tests segment accounted for the largest share of
  the Biologics Safety Testing market

The growth of the global biologics safety testing
market is driven by factors such as the growth in
the biologics and biosimilars markets, growing
concerns over cell culture contamination, and
rising biopharmaceuticals RD activities and
investments.

3
Biologics Safety Testing Market worth 6.2
billion by 2026
The report "Biologics Safety Testing Market by
Product Service (Consumables, Instrument,
Services), Application (Vaccine, Monoclonal
Antibodies, Blood products, Cell Gene Therapy
Products), Test Type (Endotoxin, Myoplasm,
Sterility Test) - Global Forecast to 2026" The
global biologics safety testing market is
projected to reach USD 6.2 billion by 2026 from
USD 3.4 billion in 2021, at a CAGR of 12.4
during the forecast period. The growth of the
global biologics safety testing market is driven
by factors such as the growth in the biologics
and biosimilars markets, growing concerns over
cell culture contamination, and rising
biopharmaceuticals RD activities and
investments. Browse 142 market data Tables and 42
Figures spread through 185 Pages and in-depth TOC
on "Biologics Safety Testing Market by Product
Service (Consumables, Instrument, Services),
Application (Vaccine, Monoclonal Antibodies,
Blood products, Cell Gene Therapy Products),
Test Type (Endotoxin, Myoplasm, Sterility Test) -
Global Forecast to 2026"View detailed Table of
Content here - https//www.marketsandmarkets.com/M
arket-Reports/biologics-safety-testing-market-3462
4144.html
4
About MarketsandMarkets
MarketsandMarkets provides quantified B2B
research on 30,000 high growth niche
opportunities/threats which will impact 70 to
80 of worldwide companies revenues. Currently
servicing 7500 customers worldwide including 80
of global Fortune 1000 companies as clients.
Almost 75,000 top officers across eight
industries worldwide approach MarketsandMarkets
for their painpoints around revenues
decisions. Our 850 fulltime analyst and SMEs at
MarketsandMarkets are tracking global high
growth markets following the "Growth Engagement
Model GEM". The GEM aims at proactive
collaboration with the clients to identify new
opportunities, identify most important customers,
write "Attack, avoid and defend" strategies,
identify sources of incremental revenues for both
the company and its competitors.
MarketsandMarkets now coming up with 1,500
MicroQuadrants (Positioning top players across
leaders, emerging companies, innovators,
strategic players) annually in high growth
emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve. MarketsandMarketss flagship
competitive intelligence and market research
platform, "Knowledgestore" connects over 200,000
markets and entire value chains for deeper
understanding of the unmet insights along with
market sizing and forecasts of niche markets.
5
Contact
Mr. Aashish Mehra MarketsandMarkets INC. 630
Dundee Road Suite 430 Northbrook, IL 60062 USA
1-888-600-6441 sales_at_marketsandmarkets.com